V Lorén1,2, A Garcia-Jaraquemada1, J E Naves1, X Carmona1, M Mañosa1,2,3, A M Aransay2,4, J L Lavin4, I Sánchez5, E Cabré1,2,3, J Manyé1,2, E Domènech1,2,3. 1. IBD Research Group, Germans Trias i Pujol Research Institute (IGTP), Badalona, Catalonia, Spain. 2. Centro de Investigación Biomédica en Red (CIBER), Madrid, Spain. 3. Gastroenterology Department, Germans Trias i Pujol University Hospital, Badalona, Catalonia, Spain. 4. Genome Analysis Platform, CIC bioGUNE, Derio, Bizkaia, Spain. 5. Functional Biology and Experimental Therapeutics Laboratory, Functional and Translational Neurogenetics Unit, Department of Neurosciences, Germans Trias i Pujol Research Institute, Badalona, Catalonia, Spain.
Abstract
BACKGROUND AND AIMS: Steroid-refractoriness is a common and unpredictable phenomenon in ulcerative colitis [UC], but there are no conclusive studies on the molecular functions involved. We aimed to assess the mechanism of action related to steroid failure by integrating transcriptomic data from UC patients, and updated molecular data on UC and glucocorticoids. METHODS: MicroRNA [miRNA] and mRNA expression were evaluated by sequencing and microarrays, respectively, from rectal biopsies of patients with moderately-to-severe active UC, obtained before and on the third day of steroid treatment. The differential results were integrated into the mathematical models generated by a systems biology approach. RESULTS: This computational approach identified 18 proteins that stand out either by being associated with the mechanism of action or by providing a means to classify the patients according to steroid response. Their biological functions have been linked to inflammation, glucocorticoid-induced transcription and angiogenesis. All the selected proteins except ANP32E [a chaperone which has been linked to the exchange of H2A.z histone and promotes glucocorticoid receptor-induced transcription] had previously been related to UC and/or glucocorticoid-induced biological actions. Western blot and immunofluorescence assays confirmed the implication of this chaperone in steroid failure in patients with active UC. CONCLUSIONS: A systems biology approach allowed us to identify a comprehensive mechanism of action of steroid-refractoriness, highlighting the key role of steroid-induced transcription and the potential implication of ANP32E in this phenomenon.
BACKGROUND AND AIMS: Steroid-refractoriness is a common and unpredictable phenomenon in ulcerative colitis [UC], but there are no conclusive studies on the molecular functions involved. We aimed to assess the mechanism of action related to steroid failure by integrating transcriptomic data from UC patients, and updated molecular data on UC and glucocorticoids. METHODS: MicroRNA [miRNA] and mRNA expression were evaluated by sequencing and microarrays, respectively, from rectal biopsies of patients with moderately-to-severe active UC, obtained before and on the third day of steroid treatment. The differential results were integrated into the mathematical models generated by a systems biology approach. RESULTS: This computational approach identified 18 proteins that stand out either by being associated with the mechanism of action or by providing a means to classify the patients according to steroid response. Their biological functions have been linked to inflammation, glucocorticoid-induced transcription and angiogenesis. All the selected proteins except ANP32E [a chaperone which has been linked to the exchange of H2A.z histone and promotes glucocorticoid receptor-induced transcription] had previously been related to UC and/or glucocorticoid-induced biological actions. Western blot and immunofluorescence assays confirmed the implication of this chaperone in steroid failure in patients with active UC. CONCLUSIONS: A systems biology approach allowed us to identify a comprehensive mechanism of action of steroid-refractoriness, highlighting the key role of steroid-induced transcription and the potential implication of ANP32E in this phenomenon.
Authors: Alba Simats; Laura Ramiro; Raquel Valls; Helena de Ramón; Paula García-Rodríguez; Cyrille Orset; Laura Artigas; Teresa Sardon; Anna Rosell; Joan Montaner Journal: Neurotherapeutics Date: 2022-02-28 Impact factor: 6.088
Authors: Maria L Lozano; Cristina Segú-Vergés; Mireia Coma; María T Álvarez-Roman; José R González-Porras; Laura Gutiérrez; David Valcárcel; Nora Butta Journal: Int J Mol Sci Date: 2021-06-27 Impact factor: 5.923
Authors: Guillem Jorba; Joaquim Aguirre-Plans; Valentin Junet; Cristina Segú-Vergés; José Luis Ruiz; Albert Pujol; Narcís Fernández-Fuentes; José Manuel Mas; Baldo Oliva Journal: PLoS One Date: 2020-02-13 Impact factor: 3.240
Authors: Bryan Linggi; Vipul Jairath; Guangyong Zou; Lisa M Shackelton; Dermot P B McGovern; Azucena Salas; Bram Verstockt; Mark S Silverberg; Shadi Nayeri; Brian G Feagan; Niels Vande Casteele Journal: Sci Rep Date: 2021-09-14 Impact factor: 4.996
Authors: Ignacio Durán; Daniel Castellano; Javier Puente; Lidia Martín-Couce; Esther Bello; Urbano Anido; José Manuel Mas; Luis Costa Journal: Oncotarget Date: 2022-01-27